TELA / TELA Bio, Inc. (TELA) CEO Tony Koblish on Q3 2021 Results - Earnings Call Transcript

TELA Bio, Inc. (TELA) came out with a quarterly loss of $0.46 per share versus the Zacks Consensus Estimate of a loss of $0.58. This compares to loss more_horizontal

TELA Bio, Inc. (TELA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate re more_horizontal

TELA Bio, Inc. (NASDAQ:TELA ) Q1 2023 Earnings Conference Call May 11, 2023 6:00 PM ET Company Participants Louisa Smith - Gilmartin Group Tony Koblis more_horizontal

TELA Bio TELA shares are trading lower after the company priced a 4.75 million share offering at $9.50 per share. more_horizontal

TELA Bio, Inc. (NASDAQ:TELA ) Q4 2022 Results Conference Call March 21, 2023 4:30 PM ET Company Participants Louisa Smith - Gilmartin Group Tony Kobli more_horizontal

TELA Bio, Inc. (TELA) delivered earnings and revenue surprises of 10.34% and 12.62%, respectively, for the quarter ended December 2022. Do the numbers more_horizontal

MALVERN, Pa., Feb. 28, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on p more_horizontal

TELA Bio, Inc. (NASDAQ:TELA ) Q3 2022 Results Conference Call November 9, 2022 4:30 PM ET Company Participants Greg Chodaczek - Gilmartin Group Tony K more_horizontal